The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010352:Patient Dropouts; D010629:Phenformin / Q000627:therapeutic use*; D010919:Placebos; D013223:Statistics as Topic; D013997:Time Factors; D014044:Tolbutamide / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; D010919:Placebos; D002784:Cholesterol; D014044:Tolbutamide; D010629:Phenformin